Immune protein could stop diabetes in its tracks
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Immunopathology & Immunotherapy
10.4K views |
+0 today
Latest advances in immunopathology diagnosis and treatment
Curated by
Alfredo Corell
 Your new post is loading...
Your new post is loading...
|
Scoop.it!
Cellular Immunology
Volume 280, Issue 1, November 2012, Pages 16–21 Shiying Shaoa, 1,Fan Heb, 1,Yan Yanga,Gang Yuana,Muxun Zhanga,Xuefeng Yua, , a Division of Endocrinology, Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology, Wuhan, PR Chinab Division of Nephrology, Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology, Wuhan, PR Chinahttp://dx.doi.org/10.1016/j.cellimm.2012.11.001,
Alfredo Corell's insight:
► This review firstly summarizes Th17 mediated immunology mechanism for T1D. ► We thoroughly introduce the characteristics of Th17 cells. ► Better understanding of mechanisms helps to develop treatment strategies for T1D. 
|
Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
video by Prof. Len Harrison (Walter+Eliza Hall) http://www.youtube.com/watch?feature=player_embedded&v=IwtphdQL6co